Obvious Ventures

Obvious Ventures is a San Francisco-based venture firm founded in 2014 by Vishal Vasishth, Ev Williams (the Twitter and Medium co-founder), and James Joaquin around an explicit thesis they call ‘world positive’ capitalism: that the next generation of trillion-dollar companies will be built on the premise that solving real human and planetary problems can also produce outsized financial returns. The firm has approximately $1.5 billion in assets under management across multiple funds and a portfolio of 130 plus companies spanning planetary health, human health, and economic health, the three macro categories Obvious organizes around. The firm is not a healthcare specialist, but human health is one of its three pillars, and it has built a credible roster of healthcare investments alongside high-profile bets in plant-based protein, decentralized clinical trials, and AI applications.

Vishal Vasishth, the firm’s co-founder and managing partner, leads the human health practice and writes most of the firm’s healthcare checks. His current and recent investments include Virta Health, the type 2 diabetes reversal platform; Galileo, the multi-specialty virtual care provider; Devoted Health, the Medicare Advantage insurer; Recursion Pharmaceuticals, the AI-driven drug discovery platform; and Iterative Health, the AI-powered gastroenterology diagnostic and clinical trial platform. The firm has also been an early backer of Beyond Meat, Medable (decentralized clinical trials), and Dexterity (AI-driven warehouse robotics), giving it a portfolio that bridges purpose-driven consumer brands and deep-tech AI infrastructure. The broader partnership includes Andrew Beebe (planetary health), and senior partners drawn from operating roles at climate, consumer, and technology companies.

Obvious writes initial checks of $5 million to $20 million across seed through Series B, with the capacity to lead at Series A and to co-lead at seed alongside specialist firms. The firm is comfortable participating in syndicates with peer specialists, including healthcare-only firms, and it reserves substantial follow-on capital for breakout companies. Obvious is decisively a value-driven check; its partners screen for mission alignment as carefully as they screen for unit economics. Geographic scope is United States with selective international deals and a clear preference for companies that fit the world-positive frame.

Founders who should approach Obvious are mission-driven operators building healthcare companies that explicitly improve outcomes at scale, full-stack care delivery models, AI applications targeting underserved patient populations, value-based primary care, and platform companies that bridge clinical and consumer experiences. The firm is particularly receptive to founders who can articulate why their company will be more financially valuable because of, not in spite of, its mission orientation. Founders building purely incremental SaaS, generic AI wrappers without a mission thesis, or pharmaceutical assets without a clear access narrative will find Obvious less aligned. Founders who treat purpose as marketing rather than as a core operating principle will not be a fit.

Entry path runs through portfolio CEOs and the firm’s network of mission-driven operators, plus warm introductions from peer impact investors, B Corp leaders, and the Medium and Twitter operating networks. Vasishth and Beebe are reachable at HLTH, ClimateTech and SOCAP-style conferences, and the firm runs a public editorial presence on its website that signals current thesis priorities. Cold inbound is read; the firm’s brand attracts a high volume and the bar for converting cold pitches is meaningful traction or a strong founder market fit story. Diligence is partner-driven and typically runs three to six weeks for competitive deals.

In a pitch, lead with the mission and the wedge, then prove the unit economics. Obvious partners want to see why your company structurally improves health outcomes or access at scale, and they want to see that you have built a business model where growth and impact compound rather than trade off. For AI healthcare founders, lead with the data, the patient outcome, and the workflow integration, with explicit attention to bias, accessibility, and trust. The firm’s added value is most powerful when founders use the Obvious community: peer mission-driven CEOs, a network of senior advisors and operators, and access to brand and storytelling resources that few traditional venture firms offer. Founders who want a partner who genuinely cares about both financial return and human outcome, and who can hold both simultaneously without flinching, will find Obvious one of the more authentic tier-one partners in human health.